Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
allegedly, alleviate, argument, baby, Barakat, BDO, Beeby, bilateral, bothersome, BRCA, breast, BSO, CaB, Canaan, Cascade, causally, Challapalli, China, Chlebowski, Climacteric, cohort, comfort, comment, complain, confirmatory, copy, crossover, customary, downturn, EDSVIOTM, Engl, entirety, estradiol, estrogen, evergreen, extremely, fatigue, FDCA, Finch, float, Floor, flushing, Formal, Gronwald, Guidozzi, Gynecol, Gynecology, Hensley, hereto, hierarchy, hollow, Holmberg, hormonal, hormone, hot, HRT, HT, Hubei, Huzarski, Inst, Iversen, JACC, Jeunemaitre, JNCI, Johnson, JonesTrading, Kaleido, Klopp, Kuller, leuprolide, LH, Lynch, MarketScan, Matthew, Med, men, menopause, Moller, Moon, motion, Narod, Natl, Neuhausen, neurotransmitter, night, noncurrent, nonprofit, noradrenergic, Oncol, oophorectomy, opposition, outbreak, PAA, PBA, Pennsylvania, Pepin, persisted, ph, PhD, phenylacetate, pilot, plaintiff, postmenopausal, premised, Prentice, Prodrug, progestin, prostate, Province, purport, Pyschosomatic, quoted, Radiation, reelection, regularly, Reshentha, respiratory, resubmission, riskreducing, RL, Robson, RT, Rudenstam, Sandler, Seibt, Semin, sensitive, serotonergic, serum, sex, Sharp, SL, Southern, stratified, SVM, tamoxifen, temperature, titled, Truven, Tyler, Ultragenyx, unadjusted, unlawful, Veru, VMS, vol, worse, Wuhan, Xavier
Filing tables
Filing exhibits
- 10-K Annual report
- 4.1 EX-4.1
- 10.27 EX-10.27
- 23.1 EX-23.1
- 23.2 EX-23.2
- 31.1 EX-31.1 Schelling Certification Pursuant to Sec 302
- 31.2 EX-31.2 Palmin Certification Pursuant to Sec 302
- 32.1 EX-32.1 Schelling Certification Pursuant to Sec 906
- 32.2 EX-32.2 Palmin Certification Pursuant to Sec 906
- Download Excel data file
- View Excel data file
Related press release
ACER similar filings
Filing view
External links
EXHIBIT 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statements on Form S-3 (File No. 333-228319) and Form S-8 (File Nos. 333-230133, 333-221566, and 333-224942) of our report dated March 7, 2019 relating to the consolidated financial statements of Acer Therapeutics Inc., appearing in the Annual Report on Form 10-K of Acer Therapeutics Inc. for the year ended December 31, 2019.
We also consent to the references to us under the heading “Experts” in such Registration Statements.
/s/ Wolf & Company, P.C.
Wolf & Company, P.C.
Boston, Massachusetts
March 18, 2020